Gan & Lee Pharmaceuticals Achieves AEO Certification, Initiating a New Era of Efficient Customs Clearance

Gan & Lee Pharmaceuticals Won the Kazakh Government Tender for Insulin Aspart and Insulin Pen

Gan & Lee Pharmaceuticals' Overseas Clinical Research on Three Insulin Products was Published in Journal Diabetes, Obesity and Metabolism

EASD 2023丨Diabetes Treatment - Basalin®️ Adds Two New Overseas Phase III Clinical Evidence

The Scientific Evaluation from EMA on the Marketing Authorisation Application of Gan & Lee Insulin Aspart biosimilar starts upon the Positive Validation Letter

The Scientific Evaluation from EMA on Marketing Authorisation Application of Gan & Lee Insulin Lispro biosimilar Starts upon the Positive Validation Letter